Table 3

Relative risks and parameter estimates (95% CIs) from Model 2

Health outcomeIMD (exp(β))Case circle versus control circle (exp(η))Change in risk at source (ζ)Rate of decay (km (γ))
Childhood cancer incidence0.999 (0.997 to 1.002)1.059 (0.797 to 1.407)−0.281 (−4.404 to 3.842)1.715 (0 to 8.151)
Childhood leukaemia incidence0.998 (0.993 to 1.002)1.023 (0.704 to 1.486)−0.650 (−12.320 to 11.020)1.148 (0 to 7.120)
Leukaemia incidence0.999 (0.998 to 1.000)1.137 (1.065 to 1.213)−0.472 (−6.043 to 5.099)0.682 (0 to 2.891)
Liver cancer incidence1.009 (1.007 to 1.010)0.984 (0.914 to 1.060)
Lung cancer incidence1.015 (1.014 to 1.015)0.936 (0.874 to 1.003)−0.096 (−0.188 to −0.004)3.598 (0 to 8.624)
Non-Hodgkin's lymphoma incidence0.999 (0.998 to 1.000)0.987 (0.945 to 1.031)
All-cause mortality1.008 (1.008 to 1.009)0.965 (0.947 to 0.984)0.187 (−0.469 to 0.843)0.762 (0 to 1.944)
Infant mortality1.017 (1.015 to 1.019)0.974 (0.600 to 1.582)0.225 (−0.529 to 0.980)6.454 (0 to 15.715)
Liver cancer mortality1.008 (1.006 to 1.010)1.004 (0.928 to 1.086)
  • For outcomes where no estimates are presented, see text for details. Relative risks correspond to a unit change in the given variable.